SPOTLIGHT -
Pharmaceutical Executive
Brussels-Two types of mutual recognition procedures are necessary to ensure that generics get to market as quickly as possible, according to the European Generics Medicines Association.
Pharma Pulse 3/19/24: BMS Completes Acquisition of Karuna, Big Questions for DC Following Massive Healthcare Hack & more
The latest news for pharma industry insiders.
Gen-Z Influence on Pharma M&A
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.
FDA Approves First Drug For NASH
Rezdiffra was approved through the accelerated approval pathway.
Recent Licensing Agreement Poised to Advance Company ADC
In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
Pharma Pulse 3/18/24: Alcohol Use Disorder Equally Linked to Suicide Across Genders, Can Personal Medical Devices Be Recycled? & more
Precision Medicine: Investments and Outcomes Expected
Precision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.